Breaking News, Collaborations & Alliances

Nutriband and Kindeva to Co-Develop Aversa Fentanyl Abuse-Deterrent Patch

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

Author Image

By: Charlie Sternberg

Associate Editor

Nutriband Inc., a company engaged in the development of prescription transdermal pharmaceutical products, has signed an addendum to the Commercial Development and Clinical Supply Agreement for its lead product, Aversa Fentanyl, that it has in place with its partner, Kindeva Drug Delivery, a global contract development and manufacturing organization (CDMO) focused on drug-device combination products. The revised agreement formalizes Nutriband and Kindeva’s exclusive product development partner...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters